Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Cardiovasc Transl Res. 2015 May 7;8(5):283–292. doi: 10.1007/s12265-015-9629-1

Table 2.

Change from baseline in patients enrolled in the CR+PHA program and standard CR program alone. P-values listed represent three-month changes from baseline within groups;

Category CR+PHA 3 Mo
Delta
P-value CR 3 Mo
Delta
P-value
Systolic Blood Pressure, mmHg −10.8±13.5, n=23 0.0009* 6.1±25.5, n=16 0.36

Diastolic Blood Pressure, mmHg −3.5±10.2, n=23 0.26 −0.3±13.2,
n=16
0.94

Weight, kg −4.0±5.2, n=23 0.001* −0.9±2.8, n=16 0.20

BMI, kg/m2 −1.2±1.7, n=23 0.006* −0.3±1.0, n=16 0.21

Total Cholesterol, mg/dL −46.9±38.3, n=18 <0.0001* −33.9±51.9,
n=11
0.06

LDL Cholesterol, mg/dL −36.7±35.7, n=18 0.0004* −35.9±47.3,
n=11
0.04*

HDL Cholesterol, mg/dL 2.8±9.0, n=18 0.20 −0.4±9.8, n=11 0.91

Triglycerides, mg/dL −39.3±69.1, n=18 0.03* −51.8±128.8,
n=11
0.22

Glucose, mg/dL −6.5±46.5, , n=12 0.64 −9.9±19.6, n=8 0.20

Weekly Exercise, min 148.1±78.5, n=21 <0.0001* 117.3±61.6,
n=13
<0.0001*

Exercise Capacity, mLO2/min/kg 2.5±2.7, n=14 0.004* 1.1±3.3, n=8 0.37

Food Score, 1-15 4.3±4.3, n=20 0.0003* +1.7±2.6, n=11 0.06

Stress Score, 1-10 −1.3±1.3, n=20 0.008* −0.6±1.6, n=11 0.22

Dartmouth QOL −5.8±1.0, n=10 0.009* −2.5±1.1, n=8 0.22
*

p<0.05.